Aurinia Pharmaceuticals (AUPH) Change in Inventory (2020 - 2026)

Aurinia Pharmaceuticals (AUPH) has 7 years of Change in Inventory data on file, last reported at $720000.0 in Q1 2026.

• Quarterly Change in Inventory fell 89.67% year-over-year to $720000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215000.0 (down 96.66% YoY) and the FY2025 annual result came in at $6.5 million, up 1454.72% from the prior year.
• Change in Inventory eased to $720000.0 in Q1 2026, from $897000.0 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $7.0 million in Q1 2023 to a low of -$1.7 million in Q3 2025.
• A 5-year average of $1.9 million and a median of $614000.0 in 2022 frame the typical range for Change in Inventory.
• The widest YoY moves for Change in Inventory: up 12341.07% in 2025, down 1130.22% in 2025.
• Tracing AUPH's Change in Inventory over 5 years: stood at $614000.0 in 2022, then soared by 1021.34% to $6.9 million in 2023, then sank by 92.53% to $514000.0 in 2024, then surged by 74.51% to $897000.0 in 2025, then dropped by 19.73% to $720000.0 in 2026.
• The last three Change in Inventory figures came in at $720000.0 (Q1 2026), $897000.0 (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.